North Brunswick, NJ, United States of America

Anne R Bellemin

This inventor holds 1 USPTO granted patent. Top assignee: Hoffmann-La Roche Inc.. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anne R Bellemin. Retrieved from https://idiyas.com/inventor/anne-r-bellemin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Anne R Bellemin

Introduction

Anne R Bellemin is a notable inventor based in North Brunswick, NJ (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral compounds. Her work has the potential to impact the treatment of viral infections, including HIV.

Latest Patents

Anne R Bellemin holds 1 patent for her invention titled "Substituted amino-benzodiazepines having antiviral activity." This patent describes novel substituted 2-amino-5-(1H-pyrrol-2-yl)-3H-1,4-benzodiazepines and compositions containing these compounds for the treatment and prophylaxis of viral infections.

Career Highlights

Bellemin is currently employed at Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. Her role involves research and development focused on innovative solutions for viral infections. Her expertise in medicinal chemistry has been instrumental in advancing her projects.

Collaborations

Throughout her career, Anne has collaborated with esteemed colleagues, including Ming-Chu Hsu and Steve Yik-Kai Tam. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Anne R Bellemin's contributions to antiviral research exemplify the impact of innovation in the pharmaceutical industry. Her work not only advances scientific knowledge but also holds promise for improving public health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…